A critical advance in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various types of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research